If this is not your name, click here.
| | If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| |  Nicotine Inhaler Launched In United Kingdom SAN ANTONIO, TX -- December 16, 1997 -- Pharmacia & Upjohn, Inc. launched the Nicorette(R) Inhaler as an over-the-counter product in the United Kingdom today. The nicotine inhaler is the first and only form of nicotine replacement therapy designed to combat the problems of both physical and behavioural dependency associated with smoking. It gives effective, active relief from nicotine cravings while offering an alternative hand-to-mouth activity. The United Kingdom and the other European countries where the Inhaler has already been launched represents approximately 20 percent of the worldwide NRT market and the United States accounts for almost 50 percent. The Inhaler was initially launched in Denmark in September, 1996, and subsequently introduced in Sweden, Italy, Austria and The Netherlands. It is to be released in the United States next year. "The Nicorette Inhaler is a revolutionary addition to the range of nicotine replacement therapies currently available,” said professor Robert West of St. George's Hospital Medical School, University of London, who carried out a large clinical trial using the Inhaler. “It reduces cravings and improves quit rates and is the only product which addresses both the physical withdrawal and behavioural problems of giving up smoking." In clinical trials, patients using the nicotine inhaler were almost half as likely to have the urge to smoke, as well as suffer from irritability and difficulty in concentrating, compared to the group that used placebo inhalers. The Inhaler consists of a mouthpiece and a cartridge containing nicotine. The smoker puffs on the mouthpiece to inhale the nicotine which is then absorbed through the lining of the mouth. The Inhaler provides about 30 percent of the nicotine a smoker gets from cigarettes. It does not contain any of the harmful substances such as tar and carbon monoxide found in tobacco smoke which cause smoking-related diseases like lung cancer. Because there is no such thing as a typical smoking pattern or standard level of nicotine dependence, there are different forms of NRT available (patch, gum and nasal spray) to suit the needs of the individual. The nicotine inhaler is recommended by Pharmacia & Upjohn for smokers who show a high behavioural dependence and smoke twenty or less cigarettes per day. More information on: Nicorette(R), Pharmacia & Upjohn
|
